Watch Demo

Active Pharmaceutical Ingredients Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2023

Active Pharmaceutical Ingredients Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2023
  • Publish Date:April 2018

  • Number of Pages:115

  • Report ID:5392625

  • Format:PDF

  • Publisher:Transparency Market Research

$ 5795


Global Active Pharmaceutical ingredients Market: Overview
Active pharmaceutical ingredients (APIs) are bulk drug products that are used as raw materials for formulations.APIs of good quality are essential for the manufacture of effective and safe medicines.

However, not all pharmaceutical companies possess in-house API manufacturing capabilities. Furthermore, a single company cannot produce all the APIs required for their formulation offerings.

The report provides detailed qualitative analysis of the market dynamics that affect the growth of the global market.Factors responsible for driving and restraining the growth of the global API market and future opportunities has been provided in the market overview section.

This section of the report also provides comprehensive market comparative analysis and market attractiveness analysis for the global market by geography for the base year, Porter’s Five Forces analysis, and market share analysis by key players (%) for the base year, operating in the active pharmaceutical ingredients market. The report also encompasses detailed event impact analysis and value chain analysis for the global market.

Global Active Pharmaceutical ingredients Market: Segmentations
The global market has been broadly segmented on the basis of manufacturing process, type of API, types of drugs, therapeutic areas and geography.This report analyzes the current scenario as well as future market potential for market globally.

This report comprises an elaborate executive summary, demonstrating a snapshot on market dynamics of various segments and sub-segments in a precise manner. Moreover, executive summary also comprises a waterfall chart, which reflects the market size of various segments in descending order.

The global API market is categorized in to captive manufacturing and contract manufacturing.Types of active pharmaceutical ingredients described in the global market include synthetic chemical API and biological API.

Branded prescription drugs, generic prescription drugs, and over-the-counter drugs are various types of drugs covered in the global market.The global market encompasses various therapeutic areas such as cardiovascular disorders, oncology, metabolic disorders, neurological disorders, musculoskeletal disorders, NSAIDs and other therapeutic uses (such as infectious diseases).

The market for these types has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers.

Global Active Pharmaceutical ingredients Market: Regional Analysis
Geographies discussed and analyzed in the global market include North America, Europe, Asia Pacific, and Rest of the World. In addition the report also comprises the precise and detailed country wise analysis for the global active pharmaceutical ingredients market such as North America (U.S. and Canada), Asia Pacific (China, Japan, India and Rest of Asia Pacific), and Europe (Germany, U.K. and Rest of Europe). The market size and forecast in terms of US$ Mn for each segment has been provided for the period from 2013 to 2023. The report on the market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2017 to 2023, considering 2016 as the base year.

Global Active Pharmaceutical ingredients Market: Competitive Landscape
A list of recommendations have been provided for new entrants to help establish a strong presence and for existing market players to take strategic decisions and to increase their market shares in the global active pharmaceutical ingredient market.The report concludes with the profiles of major players in the market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments.

Major players profiled in this report include Allergan plc, BASF SE, Boehringer Ingelheim Group, Cambrex Corporation, Dr. Reddy’s Laboratories Ltd., Lonza Group, Mylan, Inc., Sandoz (Novartis AG), Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and WuXi Apptec.

Key Segments of the Global Active Pharmaceutical Ingredients Market

By Manufacturing Process
Captive Manufacturing
Contract Manufacturing

By API Type
Synthetic Chemical API
Biological API

By Drug Type
Branded Prescription Drugs
Generic Prescription Drugs
OTC Prescription Drugs

By Therapeutic Area
Cardiovascular Disorders
Metabolic Disorders
Neurological Disorders
Musculoskeletal Disorders
Other Therapeutics Uses

By Geography
North America
Rest of Europe
Rest of Asia Pacific
Rest of the World (RoW)

Table of contents

Chapter 1 Preface

Chapter 2 Executive Summary
2.1 Introduction
2.2 Global Market: Market Snapshot
2.3 Comparative Analysis: Global Active Pharmaceutical Ingredients Market, by Geography (2015 & 2023)
2.4 Waterfall Diagram: Global API Market Revenue, by Therapeutic Area, 2015 (US$ Mn)

Chapter 3 Market Overview
3.1 Introduction
3.2 Market Dynamics
3.2.1 Drivers Increase in healthcare expenditure to drive market growth Rapidly aging of global population expected to aid growth of the API market Increase in Abbreviated New Drug Applications (ANDA) in the recent past to boost the demand for APIs
3.2.2 Restraint Adverse regulatory policies to be an important restraining factor
3.2.3 Opportunity Patent Expiry of Major Biological Drugs in the U.S. and EU Growth of the healthcare market in Asia-Pacific and rest of the world (RoW) segments
3.3 Event Impact Analysis
3.4 Value Chain Analysis
3.5 Porter's Five Forces Analysis
3.6 Market Attractiveness Analysis: Global Market, by Geography, 2015
3.7 Competitive Landscape: Global Market, by Key Players, 2015 (USD Million)

Chapter 4 By Manufacturing Process
4.1 Introduction
4.2 Captive Manufacturing Market Revenue, 2013-2023 (US$ Mn)
4.3 Contract Manufacturing Market Revenue, 2013-2023 (US$ Mn)

Chapter 5 By API Type
5.1 Introduction
5.2 Synthetic Chemical Market Revenue, 2013-2023 (US$ Mn)
5.3 API Biological API Market Revenue, 2013-2023 (US$ Mn)

Chapter 6 By Drug Type
6.1 Introduction
6.2 API Market Revenue for Branded Prescription Drugs, 2013-2023 (US$ Mn)
6.3 API Market Revenue for Generic Prescription Drugs, 2013-2023 (US$ Mn)
6.4 API Market Revenue for OTC Prescription Drugs, 2013-2023 (US$ Mn)

Chapter 7 By Therapeutic Area
7.1 Introduction
7.2 API Market Revenue for Cardiovascular Disorders Drug, 2013-2023 (US$ Mn)
7.3 API Market for Drugs for Metabolic Disorders, 2013-2023 (US$ Mn)
7.4 API Market for Drugs for Neurological Disorders, 2013-2023 (US$ Mn)
7.5 API Market for Drugs for Oncology, 2013-2023 (US$ Mn)
7.6 API Market for Drugs for Musculoskeletal Disorders, 2013-2023 (US$ Mn)
7.7 API Market for NSAIDs, 2013-2023 (US$ Mn)
7.8 API Market for Drugs for Other Therapeutics Uses, 2013-2023 (US$ Mn)

Chapter 8 By Region
8.1 Introduction
8.2 North America API Market Revenue, by Country, 2013-2023 (US$ Mn)
8.2.1 U.S. API Market Revenue,, 2013-2023, (US$ Mn)
8.2.2 Canada API Market Revenue, 2013-2023, (US$ Mn)
8.3 Asia-Pacific Market Revenue, by Country, 2013-2023 (US$ Mn)
8.3.1 China API Market Revenue,, 2013-2023, (US$ Mn)
8.3.2 Japan API Market Revenue,, 2013-2023, (US$ Mn)
8.3.3 India API Market Revenue,, 2013-2023, (US$ Mn)
8.3.4 Rest of Asia-Pacific API Market Revenue,, 2013-2023, (US$ Mn)
8.4 Europe
8.4.1 Germany API Market Revenue,, 2013-2023, (US$ Mn)
8.4.2 U.K. API Market Revenue,, 2013-2023, (US$ Mn)
8.4.3 Rest of Europe API Market Revenue,, 2013-2023, (US$ Mn)
8.5 Rest of the World

Chapter 9 Recommendations
9.1 Enhance manufacturing capacity through acquisitions in targeted geographies
9.2 Achieve cost leadership in specific API molecules

Chapter 10 Company Profiles
10.1 Allergan plc
10.2 BASF SE
10.3 Boehringer Ingelheim GmbH
10.4 Cambrex Corporation
10.5 Dr. Reddy's Laboratories
10.6 Lonza Group
10.7 Mylan N.V.
10.8 Pfizer, Inc.
10.9 Sandoz (Novartis AG)
10.10 Teva Pharmaceutical Industries Ltd.
10.11 WuXi AppTec


Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.